Peter Fenwick

2.8k total citations · 1 hit paper
36 papers, 1.7k citations indexed

About

Peter Fenwick is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Peter Fenwick has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Peter Fenwick's work include Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Pediatric health and respiratory diseases (7 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Peter Fenwick is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Pediatric health and respiratory diseases (7 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Peter Fenwick collaborates with scholars based in United Kingdom, United States and Finland. Peter Fenwick's co-authors include Louise Donnelly, Peter J. Barnes, Kazuhiro Ito, Robert Newton, Richard Russell, Jonathan Baker, Kirandeep K. Chana, James A. Heward, David Sims and Ian Goodhead and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Peter Fenwick

34 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correction: Corrigendum: Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes

2015 322 citations Peter Fenwick, Louise Donnelly et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Fenwick United Kingdom	19	606	448	372	284	177	36	1.7k
Misako Ito Japan	14	846 1.4×	1.1k 2.5×	977 2.6×	353 1.2×	99 0.6×	66	2.5k
Sang Yong Lee South Korea	28	1.4k 2.3×	468 1.0×	302 0.8×	206 0.7×	140 0.8×	147	4.0k
Carolyn J. Baglole Canada	33	980 1.6×	698 1.6×	561 1.5×	771 2.7×	15 0.1×	93	3.2k
Thomas H. March United States	25	858 1.4×	579 1.3×	259 0.7×	214 0.8×	9 0.1×	59	2.1k
Katerina Kechris United States	33	2.0k 3.2×	755 1.7×	483 1.3×	258 0.9×	11 0.1×	151	3.7k
Donald Massaro United States	27	812 1.3×	1.4k 3.1×	361 1.0×	258 0.9×	14 0.1×	70	2.6k
Yafang Li China	25	685 1.1×	188 0.4×	111 0.3×	120 0.4×	12 0.1×	104	1.9k
Ting‐Chuan Wang Taiwan	25	683 1.1×	109 0.2×	143 0.4×	143 0.5×	52 0.3×	86	2.3k
Xiaoyu Jiang China	30	693 1.1×	136 0.3×	140 0.4×	406 1.4×	30 0.2×	104	2.7k

Countries citing papers authored by Peter Fenwick

Since Specialization

Citations

This map shows the geographic impact of Peter Fenwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fenwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fenwick more than expected).

Fields of papers citing papers by Peter Fenwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Fenwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fenwick. The network helps show where Peter Fenwick may publish in the future.

Co-authorship network of co-authors of Peter Fenwick

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Fenwick. A scholar is included among the top collaborators of Peter Fenwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Fenwick. Peter Fenwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker, Jonathan, et al.. (2025). Chronic Obstructive Pulmonary Disease Airway Epithelial Cell–derived Extracellular Vesicles Spread Cellular Senescence via MicroRNA-34a. American Journal of Respiratory Cell and Molecular Biology. 73(2). 210–220. 5 indexed citations

Finney, Lydia, Melody G. Duvall, Dexter Wiseman, et al.. (2025). Select Airway Specialized Proresolving Mediators Are Associated with Recovery from Nonviral Chronic Obstructive Pulmonary Disease Exacerbations. American Journal of Respiratory and Critical Care Medicine. 211(5). 803–813. 2 indexed citations

Finney, Lydia, Peter Fenwick, Samuel V. Kemp, et al.. (2024). Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 328(1). L120–L133. 1 indexed citations

Fenwick, Peter, et al.. (2024). Navitoclax inhibits senescence in human alveolar type 2 cells from COPD patients. PA897–PA897. 1 indexed citations

Fenwick, Peter, et al.. (2024). Effect of the putative senotherapy, Fisetin on small airway epithelial cells in COPD. PA4423–PA4423.

Fenwick, Peter, Patrizia Viola, Raphaël Lemaire, et al.. (2024). Effect of the novel senolytic drug, BCL-xL PROTAC, on small airway epithelial cells in COPD. PA4429–PA4429.

Baker, Jonathan, Peter Fenwick, Sarah Elkin, et al.. (2022). IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD. JCI Insight. 7(15). 15 indexed citations

Parnia, Sam, Stephen G. Post, Matthew T. Lee, et al.. (2022). Guidelines and standards for the study of death and recalled experiences of death––a multidisciplinary consensus statement and proposed future directions. Annals of the New York Academy of Sciences. 1511(1). 5–21. 26 indexed citations

Finney, Lydia, Nicholas Glanville, Hugo Farne, et al.. (2020). Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon. Journal of Allergy and Clinical Immunology. 147(2). 510–519.e5. 100 indexed citations

10.

Finney, Lydia, Kylie Belchamber, Peter Fenwick, et al.. (2018). Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 199(12). 1496–1507. 40 indexed citations

11.

Fenwick, Peter, et al.. (2018). Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology. 60(4). 445–453. 33 indexed citations

12.

Yanagisawa, Satoru, Jonathan Baker, Chaitanya Vuppusetty, et al.. (2018). The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure. PLoS ONE. 13(3). e0193921–e0193921. 59 indexed citations

13.

Fenwick, Peter, Patricia Macedo, Iain Kilty, Peter J. Barnes, & Louise Donnelly. (2015). Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells. PLoS ONE. 10(6). e0128757–e0128757. 45 indexed citations

14.

Yeo, Samuel Chao Ming, Peter Fenwick, Peter J. Barnes, & Louise Donnelly. (2015). Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation. OA487–OA487. 1 indexed citations

15.

Fenwick, Peter, Vikram R. Rao, Iain Kilty, et al.. (2013). Inhibition of IRAK4 suppresses chemokine release from human bronchial epithelial cells. European Respiratory Journal. 42(Suppl 57). 4879–4879. 1 indexed citations

16.

Chana, Kirandeep K., Peter Fenwick, Andrew G. Nicholson, Peter J. Barnes, & Louise Donnelly. (2013). Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. 133(1). 207–216.e11. 43 indexed citations

17.

Mercado, Nicolas, Rajesh K. Thimmulappa, Catherine Thomas, et al.. (2011). Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochemical and Biophysical Research Communications. 406(2). 292–298. 164 indexed citations

18.

Bugeon, Laurence, Louise Donnelly, Ursula Straschil, et al.. (2011). Regulation of IL-17 in chronic inflammation in the human lung. Clinical Science. 120(12). 515–524. 41 indexed citations

19.

Smith, Susan J., L B Cieslinski, Robert Newton, et al.. (2004). Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a Selective Inhibitor of Phosphodiesterase 7: In Vitro Studies in Human Monocytes, Lung Macrophages, and CD8+ T-Lymphocytes. Molecular Pharmacology. 66(6). 1679–1689. 136 indexed citations

20.

Fenwick, Peter, C. J. Ryan, Shiranee Sriskandan, & Jonathan Cohen. (2003). Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens*. Critical Care Medicine. 31(1). 171–178. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact